nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolic acid—Mycophenolate mofetil—systemic scleroderma	0.444	1	CrCtD
Mycophenolic acid—psoriasis—systemic scleroderma	0.24	1	CtDrD
Mycophenolic acid—UGT1A7—Mycophenolate mofetil—systemic scleroderma	0.0816	0.328	CbGbCtD
Mycophenolic acid—IMPDH2—Mycophenolate mofetil—systemic scleroderma	0.059	0.237	CbGbCtD
Mycophenolic acid—IMPDH1—Mycophenolate mofetil—systemic scleroderma	0.0469	0.188	CbGbCtD
Mycophenolic acid—UGT1A6—Mycophenolate mofetil—systemic scleroderma	0.0339	0.136	CbGbCtD
Mycophenolic acid—UGT1A9—Mycophenolate mofetil—systemic scleroderma	0.00989	0.0397	CbGbCtD
Mycophenolic acid—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.00936	0.0376	CbGbCtD
Mycophenolic acid—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.00809	0.0325	CbGbCtD
Mycophenolic acid—UGT1A7—digestive system—systemic scleroderma	0.000662	0.169	CbGeAlD
Mycophenolic acid—UGT1A6—digestive system—systemic scleroderma	0.000515	0.131	CbGeAlD
Mycophenolic acid—IMPDH2—smooth muscle tissue—systemic scleroderma	0.000312	0.0795	CbGeAlD
Mycophenolic acid—IMPDH1—smooth muscle tissue—systemic scleroderma	0.00031	0.079	CbGeAlD
Mycophenolic acid—IMPDH2—skin of body—systemic scleroderma	0.000308	0.0785	CbGeAlD
Mycophenolic acid—UGT1A9—digestive system—systemic scleroderma	0.000278	0.0708	CbGeAlD
Mycophenolic acid—IMPDH2—digestive system—systemic scleroderma	0.000247	0.0628	CbGeAlD
Mycophenolic acid—IMPDH2—tendon—systemic scleroderma	0.000235	0.0598	CbGeAlD
Mycophenolic acid—IMPDH1—tendon—systemic scleroderma	0.000233	0.0594	CbGeAlD
Mycophenolic acid—UGT2B7—digestive system—systemic scleroderma	0.000224	0.0571	CbGeAlD
Mycophenolic acid—IMPDH2—lung—systemic scleroderma	0.000206	0.0525	CbGeAlD
Mycophenolic acid—IMPDH1—lung—systemic scleroderma	0.000205	0.0521	CbGeAlD
Mycophenolic acid—UGT1A1—digestive system—systemic scleroderma	0.000191	0.0485	CbGeAlD
Mycophenolic acid—Abdominal pain—Azathioprine—systemic scleroderma	1.72e-05	0.000272	CcSEcCtD
Mycophenolic acid—Body temperature increased—Azathioprine—systemic scleroderma	1.72e-05	0.000272	CcSEcCtD
Mycophenolic acid—Skin disorder—Lisinopril—systemic scleroderma	1.71e-05	0.000271	CcSEcCtD
Mycophenolic acid—Malaise—Mycophenolate mofetil—systemic scleroderma	1.71e-05	0.00027	CcSEcCtD
Mycophenolic acid—Hyperhidrosis—Lisinopril—systemic scleroderma	1.7e-05	0.00027	CcSEcCtD
Mycophenolic acid—Diarrhoea—Captopril—systemic scleroderma	1.7e-05	0.00027	CcSEcCtD
Mycophenolic acid—Vertigo—Mycophenolate mofetil—systemic scleroderma	1.7e-05	0.000269	CcSEcCtD
Mycophenolic acid—Syncope—Mycophenolate mofetil—systemic scleroderma	1.7e-05	0.000269	CcSEcCtD
Mycophenolic acid—Erectile dysfunction—Prednisone—systemic scleroderma	1.7e-05	0.000268	CcSEcCtD
Mycophenolic acid—Leukopenia—Mycophenolate mofetil—systemic scleroderma	1.69e-05	0.000268	CcSEcCtD
Mycophenolic acid—Feeling abnormal—Leflunomide—systemic scleroderma	1.69e-05	0.000268	CcSEcCtD
Mycophenolic acid—Mood swings—Methotrexate—systemic scleroderma	1.69e-05	0.000267	CcSEcCtD
Mycophenolic acid—Nausea—Mometasone—systemic scleroderma	1.68e-05	0.000266	CcSEcCtD
Mycophenolic acid—Anorexia—Lisinopril—systemic scleroderma	1.68e-05	0.000266	CcSEcCtD
Mycophenolic acid—Gastrointestinal pain—Leflunomide—systemic scleroderma	1.68e-05	0.000266	CcSEcCtD
Mycophenolic acid—Weight increased—Prednisone—systemic scleroderma	1.68e-05	0.000265	CcSEcCtD
Mycophenolic acid—Ataxia—Methotrexate—systemic scleroderma	1.67e-05	0.000265	CcSEcCtD
Mycophenolic acid—Palpitations—Mycophenolate mofetil—systemic scleroderma	1.67e-05	0.000265	CcSEcCtD
Mycophenolic acid—Weight decreased—Prednisone—systemic scleroderma	1.67e-05	0.000264	CcSEcCtD
Mycophenolic acid—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	1.66e-05	0.000263	CcSEcCtD
Mycophenolic acid—Hyperglycaemia—Prednisone—systemic scleroderma	1.66e-05	0.000263	CcSEcCtD
Mycophenolic acid—Cough—Mycophenolate mofetil—systemic scleroderma	1.65e-05	0.000261	CcSEcCtD
Mycophenolic acid—Hypotension—Lisinopril—systemic scleroderma	1.65e-05	0.000261	CcSEcCtD
Mycophenolic acid—Dizziness—Captopril—systemic scleroderma	1.65e-05	0.000261	CcSEcCtD
Mycophenolic acid—Liver function test abnormal—Methotrexate—systemic scleroderma	1.64e-05	0.00026	CcSEcCtD
Mycophenolic acid—Convulsion—Mycophenolate mofetil—systemic scleroderma	1.64e-05	0.00026	CcSEcCtD
Mycophenolic acid—Hypertension—Mycophenolate mofetil—systemic scleroderma	1.63e-05	0.000259	CcSEcCtD
Mycophenolic acid—Body temperature increased—Leflunomide—systemic scleroderma	1.62e-05	0.000257	CcSEcCtD
Mycophenolic acid—Abdominal pain—Leflunomide—systemic scleroderma	1.62e-05	0.000257	CcSEcCtD
Mycophenolic acid—Arthralgia—Mycophenolate mofetil—systemic scleroderma	1.61e-05	0.000255	CcSEcCtD
Mycophenolic acid—Myalgia—Mycophenolate mofetil—systemic scleroderma	1.61e-05	0.000255	CcSEcCtD
Mycophenolic acid—Chest pain—Mycophenolate mofetil—systemic scleroderma	1.61e-05	0.000255	CcSEcCtD
Mycophenolic acid—Neuropathy peripheral—Prednisone—systemic scleroderma	1.61e-05	0.000255	CcSEcCtD
Mycophenolic acid—Breast disorder—Methotrexate—systemic scleroderma	1.61e-05	0.000255	CcSEcCtD
Mycophenolic acid—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	1.61e-05	0.000254	CcSEcCtD
Mycophenolic acid—Anxiety—Mycophenolate mofetil—systemic scleroderma	1.61e-05	0.000254	CcSEcCtD
Mycophenolic acid—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	1.6e-05	0.000253	CcSEcCtD
Mycophenolic acid—Insomnia—Lisinopril—systemic scleroderma	1.59e-05	0.000252	CcSEcCtD
Mycophenolic acid—Discomfort—Mycophenolate mofetil—systemic scleroderma	1.59e-05	0.000252	CcSEcCtD
Mycophenolic acid—Paraesthesia—Lisinopril—systemic scleroderma	1.58e-05	0.000251	CcSEcCtD
Mycophenolic acid—Vomiting—Captopril—systemic scleroderma	1.58e-05	0.000251	CcSEcCtD
Mycophenolic acid—Dry mouth—Mycophenolate mofetil—systemic scleroderma	1.58e-05	0.000249	CcSEcCtD
Mycophenolic acid—Dyspnoea—Lisinopril—systemic scleroderma	1.57e-05	0.000249	CcSEcCtD
Mycophenolic acid—Rash—Captopril—systemic scleroderma	1.57e-05	0.000248	CcSEcCtD
Mycophenolic acid—Dermatitis—Captopril—systemic scleroderma	1.57e-05	0.000248	CcSEcCtD
Mycophenolic acid—Somnolence—Lisinopril—systemic scleroderma	1.57e-05	0.000248	CcSEcCtD
Mycophenolic acid—Headache—Captopril—systemic scleroderma	1.56e-05	0.000247	CcSEcCtD
Mycophenolic acid—Confusional state—Mycophenolate mofetil—systemic scleroderma	1.56e-05	0.000246	CcSEcCtD
Mycophenolic acid—Dyspepsia—Lisinopril—systemic scleroderma	1.55e-05	0.000246	CcSEcCtD
Mycophenolic acid—Oedema—Mycophenolate mofetil—systemic scleroderma	1.54e-05	0.000244	CcSEcCtD
Mycophenolic acid—Asthma—Methotrexate—systemic scleroderma	1.54e-05	0.000244	CcSEcCtD
Mycophenolic acid—Infection—Mycophenolate mofetil—systemic scleroderma	1.53e-05	0.000243	CcSEcCtD
Mycophenolic acid—Decreased appetite—Lisinopril—systemic scleroderma	1.53e-05	0.000243	CcSEcCtD
Mycophenolic acid—Gastrointestinal disorder—Lisinopril—systemic scleroderma	1.52e-05	0.000241	CcSEcCtD
Mycophenolic acid—Fatigue—Lisinopril—systemic scleroderma	1.52e-05	0.000241	CcSEcCtD
Mycophenolic acid—Shock—Mycophenolate mofetil—systemic scleroderma	1.52e-05	0.000241	CcSEcCtD
Mycophenolic acid—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	1.51e-05	0.00024	CcSEcCtD
Mycophenolic acid—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	1.51e-05	0.000239	CcSEcCtD
Mycophenolic acid—Pancreatitis—Methotrexate—systemic scleroderma	1.51e-05	0.000239	CcSEcCtD
Mycophenolic acid—Constipation—Lisinopril—systemic scleroderma	1.51e-05	0.000239	CcSEcCtD
Mycophenolic acid—Pain—Lisinopril—systemic scleroderma	1.51e-05	0.000239	CcSEcCtD
Mycophenolic acid—Tachycardia—Mycophenolate mofetil—systemic scleroderma	1.51e-05	0.000239	CcSEcCtD
Mycophenolic acid—Skin disorder—Mycophenolate mofetil—systemic scleroderma	1.5e-05	0.000237	CcSEcCtD
Mycophenolic acid—Bradycardia—Prednisone—systemic scleroderma	1.5e-05	0.000237	CcSEcCtD
Mycophenolic acid—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	1.49e-05	0.000236	CcSEcCtD
Mycophenolic acid—Diarrhoea—Azathioprine—systemic scleroderma	1.49e-05	0.000235	CcSEcCtD
Mycophenolic acid—Haemoglobin—Prednisone—systemic scleroderma	1.48e-05	0.000234	CcSEcCtD
Mycophenolic acid—Nausea—Captopril—systemic scleroderma	1.48e-05	0.000234	CcSEcCtD
Mycophenolic acid—Haemorrhage—Prednisone—systemic scleroderma	1.47e-05	0.000233	CcSEcCtD
Mycophenolic acid—Anorexia—Mycophenolate mofetil—systemic scleroderma	1.47e-05	0.000233	CcSEcCtD
Mycophenolic acid—Asthenia—Leflunomide—systemic scleroderma	1.47e-05	0.000233	CcSEcCtD
Mycophenolic acid—Hallucination—Prednisone—systemic scleroderma	1.47e-05	0.000232	CcSEcCtD
Mycophenolic acid—Pancytopenia—Methotrexate—systemic scleroderma	1.46e-05	0.000231	CcSEcCtD
Mycophenolic acid—Feeling abnormal—Lisinopril—systemic scleroderma	1.45e-05	0.00023	CcSEcCtD
Mycophenolic acid—Pruritus—Leflunomide—systemic scleroderma	1.45e-05	0.00023	CcSEcCtD
Mycophenolic acid—Connective tissue disorder—Prednisone—systemic scleroderma	1.45e-05	0.000229	CcSEcCtD
Mycophenolic acid—Hypotension—Mycophenolate mofetil—systemic scleroderma	1.44e-05	0.000228	CcSEcCtD
Mycophenolic acid—Gastrointestinal pain—Lisinopril—systemic scleroderma	1.44e-05	0.000228	CcSEcCtD
Mycophenolic acid—Dysuria—Methotrexate—systemic scleroderma	1.44e-05	0.000228	CcSEcCtD
Mycophenolic acid—Neutropenia—Methotrexate—systemic scleroderma	1.44e-05	0.000228	CcSEcCtD
Mycophenolic acid—Dizziness—Azathioprine—systemic scleroderma	1.44e-05	0.000227	CcSEcCtD
Mycophenolic acid—Upper respiratory tract infection—Methotrexate—systemic scleroderma	1.43e-05	0.000226	CcSEcCtD
Mycophenolic acid—Erectile dysfunction—Methotrexate—systemic scleroderma	1.42e-05	0.000224	CcSEcCtD
Mycophenolic acid—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	1.41e-05	0.000223	CcSEcCtD
Mycophenolic acid—Diarrhoea—Leflunomide—systemic scleroderma	1.4e-05	0.000222	CcSEcCtD
Mycophenolic acid—Insomnia—Mycophenolate mofetil—systemic scleroderma	1.4e-05	0.000221	CcSEcCtD
Mycophenolic acid—Abdominal pain—Lisinopril—systemic scleroderma	1.39e-05	0.000221	CcSEcCtD
Mycophenolic acid—Body temperature increased—Lisinopril—systemic scleroderma	1.39e-05	0.000221	CcSEcCtD
Mycophenolic acid—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	1.39e-05	0.00022	CcSEcCtD
Mycophenolic acid—Vomiting—Azathioprine—systemic scleroderma	1.38e-05	0.000219	CcSEcCtD
Mycophenolic acid—Pneumonia—Methotrexate—systemic scleroderma	1.38e-05	0.000218	CcSEcCtD
Mycophenolic acid—Eye disorder—Prednisone—systemic scleroderma	1.38e-05	0.000218	CcSEcCtD
Mycophenolic acid—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	1.38e-05	0.000218	CcSEcCtD
Mycophenolic acid—Somnolence—Mycophenolate mofetil—systemic scleroderma	1.37e-05	0.000217	CcSEcCtD
Mycophenolic acid—Infestation NOS—Methotrexate—systemic scleroderma	1.37e-05	0.000217	CcSEcCtD
Mycophenolic acid—Infestation—Methotrexate—systemic scleroderma	1.37e-05	0.000217	CcSEcCtD
Mycophenolic acid—Rash—Azathioprine—systemic scleroderma	1.37e-05	0.000217	CcSEcCtD
Mycophenolic acid—Dermatitis—Azathioprine—systemic scleroderma	1.37e-05	0.000217	CcSEcCtD
Mycophenolic acid—Headache—Azathioprine—systemic scleroderma	1.36e-05	0.000215	CcSEcCtD
Mycophenolic acid—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	1.36e-05	0.000215	CcSEcCtD
Mycophenolic acid—Dizziness—Leflunomide—systemic scleroderma	1.36e-05	0.000215	CcSEcCtD
Mycophenolic acid—Renal failure—Methotrexate—systemic scleroderma	1.35e-05	0.000213	CcSEcCtD
Mycophenolic acid—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	1.34e-05	0.000213	CcSEcCtD
Mycophenolic acid—Stomatitis—Methotrexate—systemic scleroderma	1.34e-05	0.000212	CcSEcCtD
Mycophenolic acid—Angiopathy—Prednisone—systemic scleroderma	1.34e-05	0.000212	CcSEcCtD
Mycophenolic acid—Conjunctivitis—Methotrexate—systemic scleroderma	1.33e-05	0.000211	CcSEcCtD
Mycophenolic acid—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	1.33e-05	0.000211	CcSEcCtD
Mycophenolic acid—Constipation—Mycophenolate mofetil—systemic scleroderma	1.32e-05	0.000209	CcSEcCtD
Mycophenolic acid—Pain—Mycophenolate mofetil—systemic scleroderma	1.32e-05	0.000209	CcSEcCtD
Mycophenolic acid—Arrhythmia—Prednisone—systemic scleroderma	1.32e-05	0.000208	CcSEcCtD
Mycophenolic acid—Sweating—Methotrexate—systemic scleroderma	1.32e-05	0.000208	CcSEcCtD
Mycophenolic acid—Haematuria—Methotrexate—systemic scleroderma	1.31e-05	0.000207	CcSEcCtD
Mycophenolic acid—Vomiting—Leflunomide—systemic scleroderma	1.3e-05	0.000206	CcSEcCtD
Mycophenolic acid—Alopecia—Prednisone—systemic scleroderma	1.3e-05	0.000206	CcSEcCtD
Mycophenolic acid—Hepatobiliary disease—Methotrexate—systemic scleroderma	1.3e-05	0.000205	CcSEcCtD
Mycophenolic acid—Epistaxis—Methotrexate—systemic scleroderma	1.29e-05	0.000205	CcSEcCtD
Mycophenolic acid—Rash—Leflunomide—systemic scleroderma	1.29e-05	0.000205	CcSEcCtD
Mycophenolic acid—Dermatitis—Leflunomide—systemic scleroderma	1.29e-05	0.000205	CcSEcCtD
Mycophenolic acid—Mental disorder—Prednisone—systemic scleroderma	1.29e-05	0.000204	CcSEcCtD
Mycophenolic acid—Nausea—Azathioprine—systemic scleroderma	1.29e-05	0.000204	CcSEcCtD
Mycophenolic acid—Headache—Leflunomide—systemic scleroderma	1.29e-05	0.000203	CcSEcCtD
Mycophenolic acid—Malnutrition—Prednisone—systemic scleroderma	1.28e-05	0.000203	CcSEcCtD
Mycophenolic acid—Agranulocytosis—Methotrexate—systemic scleroderma	1.28e-05	0.000203	CcSEcCtD
Mycophenolic acid—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	1.27e-05	0.000201	CcSEcCtD
Mycophenolic acid—Asthenia—Lisinopril—systemic scleroderma	1.26e-05	0.0002	CcSEcCtD
Mycophenolic acid—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	1.26e-05	0.0002	CcSEcCtD
Mycophenolic acid—Pruritus—Lisinopril—systemic scleroderma	1.25e-05	0.000197	CcSEcCtD
Mycophenolic acid—Haemoglobin—Methotrexate—systemic scleroderma	1.24e-05	0.000196	CcSEcCtD
Mycophenolic acid—Hepatitis—Methotrexate—systemic scleroderma	1.23e-05	0.000195	CcSEcCtD
Mycophenolic acid—Haemorrhage—Methotrexate—systemic scleroderma	1.23e-05	0.000195	CcSEcCtD
Mycophenolic acid—Pharyngitis—Methotrexate—systemic scleroderma	1.22e-05	0.000193	CcSEcCtD
Mycophenolic acid—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	1.22e-05	0.000193	CcSEcCtD
Mycophenolic acid—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	1.22e-05	0.000193	CcSEcCtD
Mycophenolic acid—Nausea—Leflunomide—systemic scleroderma	1.22e-05	0.000193	CcSEcCtD
Mycophenolic acid—Urinary tract disorder—Methotrexate—systemic scleroderma	1.22e-05	0.000193	CcSEcCtD
Mycophenolic acid—Vision blurred—Prednisone—systemic scleroderma	1.21e-05	0.000191	CcSEcCtD
Mycophenolic acid—Urethral disorder—Methotrexate—systemic scleroderma	1.21e-05	0.000191	CcSEcCtD
Mycophenolic acid—Diarrhoea—Lisinopril—systemic scleroderma	1.21e-05	0.000191	CcSEcCtD
Mycophenolic acid—Ill-defined disorder—Prednisone—systemic scleroderma	1.19e-05	0.000188	CcSEcCtD
Mycophenolic acid—Visual impairment—Methotrexate—systemic scleroderma	1.19e-05	0.000188	CcSEcCtD
Mycophenolic acid—Anaemia—Prednisone—systemic scleroderma	1.19e-05	0.000188	CcSEcCtD
Mycophenolic acid—Agitation—Prednisone—systemic scleroderma	1.18e-05	0.000187	CcSEcCtD
Mycophenolic acid—Dizziness—Lisinopril—systemic scleroderma	1.17e-05	0.000185	CcSEcCtD
Mycophenolic acid—Malaise—Prednisone—systemic scleroderma	1.16e-05	0.000183	CcSEcCtD
Mycophenolic acid—Vertigo—Prednisone—systemic scleroderma	1.15e-05	0.000182	CcSEcCtD
Mycophenolic acid—Eye disorder—Methotrexate—systemic scleroderma	1.15e-05	0.000182	CcSEcCtD
Mycophenolic acid—Syncope—Prednisone—systemic scleroderma	1.15e-05	0.000182	CcSEcCtD
Mycophenolic acid—Tinnitus—Methotrexate—systemic scleroderma	1.15e-05	0.000182	CcSEcCtD
Mycophenolic acid—Cardiac disorder—Methotrexate—systemic scleroderma	1.14e-05	0.000181	CcSEcCtD
Mycophenolic acid—Loss of consciousness—Prednisone—systemic scleroderma	1.13e-05	0.000178	CcSEcCtD
Mycophenolic acid—Vomiting—Lisinopril—systemic scleroderma	1.12e-05	0.000177	CcSEcCtD
Mycophenolic acid—Angiopathy—Methotrexate—systemic scleroderma	1.12e-05	0.000177	CcSEcCtD
Mycophenolic acid—Rash—Lisinopril—systemic scleroderma	1.11e-05	0.000176	CcSEcCtD
Mycophenolic acid—Convulsion—Prednisone—systemic scleroderma	1.11e-05	0.000176	CcSEcCtD
Mycophenolic acid—Dermatitis—Lisinopril—systemic scleroderma	1.11e-05	0.000176	CcSEcCtD
Mycophenolic acid—Mediastinal disorder—Methotrexate—systemic scleroderma	1.11e-05	0.000176	CcSEcCtD
Mycophenolic acid—Asthenia—Mycophenolate mofetil—systemic scleroderma	1.11e-05	0.000175	CcSEcCtD
Mycophenolic acid—Hypertension—Prednisone—systemic scleroderma	1.11e-05	0.000175	CcSEcCtD
Mycophenolic acid—Chills—Methotrexate—systemic scleroderma	1.1e-05	0.000175	CcSEcCtD
Mycophenolic acid—Headache—Lisinopril—systemic scleroderma	1.1e-05	0.000175	CcSEcCtD
Mycophenolic acid—Pruritus—Mycophenolate mofetil—systemic scleroderma	1.09e-05	0.000173	CcSEcCtD
Mycophenolic acid—Arthralgia—Prednisone—systemic scleroderma	1.09e-05	0.000173	CcSEcCtD
Mycophenolic acid—Myalgia—Prednisone—systemic scleroderma	1.09e-05	0.000173	CcSEcCtD
Mycophenolic acid—Anxiety—Prednisone—systemic scleroderma	1.09e-05	0.000172	CcSEcCtD
Mycophenolic acid—Alopecia—Methotrexate—systemic scleroderma	1.09e-05	0.000172	CcSEcCtD
Mycophenolic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	1.08e-05	0.000172	CcSEcCtD
Mycophenolic acid—Discomfort—Prednisone—systemic scleroderma	1.08e-05	0.000171	CcSEcCtD
Mycophenolic acid—Mental disorder—Methotrexate—systemic scleroderma	1.08e-05	0.000171	CcSEcCtD
Mycophenolic acid—Malnutrition—Methotrexate—systemic scleroderma	1.07e-05	0.00017	CcSEcCtD
Mycophenolic acid—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	1.06e-05	0.000167	CcSEcCtD
Mycophenolic acid—Nausea—Lisinopril—systemic scleroderma	1.05e-05	0.000166	CcSEcCtD
Mycophenolic acid—Oedema—Prednisone—systemic scleroderma	1.05e-05	0.000166	CcSEcCtD
Mycophenolic acid—Infection—Prednisone—systemic scleroderma	1.04e-05	0.000165	CcSEcCtD
Mycophenolic acid—Back pain—Methotrexate—systemic scleroderma	1.04e-05	0.000164	CcSEcCtD
Mycophenolic acid—Shock—Prednisone—systemic scleroderma	1.03e-05	0.000163	CcSEcCtD
Mycophenolic acid—Nervous system disorder—Prednisone—systemic scleroderma	1.03e-05	0.000163	CcSEcCtD
Mycophenolic acid—Tachycardia—Prednisone—systemic scleroderma	1.02e-05	0.000162	CcSEcCtD
Mycophenolic acid—Dizziness—Mycophenolate mofetil—systemic scleroderma	1.02e-05	0.000162	CcSEcCtD
Mycophenolic acid—Skin disorder—Prednisone—systemic scleroderma	1.02e-05	0.000161	CcSEcCtD
Mycophenolic acid—Hyperhidrosis—Prednisone—systemic scleroderma	1.01e-05	0.00016	CcSEcCtD
Mycophenolic acid—Vision blurred—Methotrexate—systemic scleroderma	1.01e-05	0.00016	CcSEcCtD
Mycophenolic acid—Anorexia—Prednisone—systemic scleroderma	9.98e-06	0.000158	CcSEcCtD
Mycophenolic acid—Ill-defined disorder—Methotrexate—systemic scleroderma	9.95e-06	0.000157	CcSEcCtD
Mycophenolic acid—Anaemia—Methotrexate—systemic scleroderma	9.91e-06	0.000157	CcSEcCtD
Mycophenolic acid—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.82e-06	0.000155	CcSEcCtD
Mycophenolic acid—Rash—Mycophenolate mofetil—systemic scleroderma	9.74e-06	0.000154	CcSEcCtD
Mycophenolic acid—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.73e-06	0.000154	CcSEcCtD
Mycophenolic acid—Headache—Mycophenolate mofetil—systemic scleroderma	9.68e-06	0.000153	CcSEcCtD
Mycophenolic acid—Malaise—Methotrexate—systemic scleroderma	9.67e-06	0.000153	CcSEcCtD
Mycophenolic acid—Vertigo—Methotrexate—systemic scleroderma	9.63e-06	0.000152	CcSEcCtD
Mycophenolic acid—Leukopenia—Methotrexate—systemic scleroderma	9.6e-06	0.000152	CcSEcCtD
Mycophenolic acid—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.54e-06	0.000151	CcSEcCtD
Mycophenolic acid—Insomnia—Prednisone—systemic scleroderma	9.47e-06	0.00015	CcSEcCtD
Mycophenolic acid—Paraesthesia—Prednisone—systemic scleroderma	9.4e-06	0.000149	CcSEcCtD
Mycophenolic acid—Cough—Methotrexate—systemic scleroderma	9.35e-06	0.000148	CcSEcCtD
Mycophenolic acid—Convulsion—Methotrexate—systemic scleroderma	9.29e-06	0.000147	CcSEcCtD
Mycophenolic acid—Dyspepsia—Prednisone—systemic scleroderma	9.22e-06	0.000146	CcSEcCtD
Mycophenolic acid—Nausea—Mycophenolate mofetil—systemic scleroderma	9.17e-06	0.000145	CcSEcCtD
Mycophenolic acid—Chest pain—Methotrexate—systemic scleroderma	9.13e-06	0.000144	CcSEcCtD
Mycophenolic acid—Arthralgia—Methotrexate—systemic scleroderma	9.13e-06	0.000144	CcSEcCtD
Mycophenolic acid—Myalgia—Methotrexate—systemic scleroderma	9.13e-06	0.000144	CcSEcCtD
Mycophenolic acid—Decreased appetite—Prednisone—systemic scleroderma	9.1e-06	0.000144	CcSEcCtD
Mycophenolic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	9.06e-06	0.000143	CcSEcCtD
Mycophenolic acid—Fatigue—Prednisone—systemic scleroderma	9.03e-06	0.000143	CcSEcCtD
Mycophenolic acid—Discomfort—Methotrexate—systemic scleroderma	9.02e-06	0.000143	CcSEcCtD
Mycophenolic acid—Constipation—Prednisone—systemic scleroderma	8.95e-06	0.000142	CcSEcCtD
Mycophenolic acid—Confusional state—Methotrexate—systemic scleroderma	8.82e-06	0.00014	CcSEcCtD
Mycophenolic acid—Infection—Methotrexate—systemic scleroderma	8.69e-06	0.000138	CcSEcCtD
Mycophenolic acid—Feeling abnormal—Prednisone—systemic scleroderma	8.63e-06	0.000137	CcSEcCtD
Mycophenolic acid—Nervous system disorder—Methotrexate—systemic scleroderma	8.58e-06	0.000136	CcSEcCtD
Mycophenolic acid—Thrombocytopenia—Methotrexate—systemic scleroderma	8.57e-06	0.000136	CcSEcCtD
Mycophenolic acid—Gastrointestinal pain—Prednisone—systemic scleroderma	8.56e-06	0.000136	CcSEcCtD
Mycophenolic acid—Skin disorder—Methotrexate—systemic scleroderma	8.5e-06	0.000135	CcSEcCtD
Mycophenolic acid—Hyperhidrosis—Methotrexate—systemic scleroderma	8.46e-06	0.000134	CcSEcCtD
Mycophenolic acid—Anorexia—Methotrexate—systemic scleroderma	8.34e-06	0.000132	CcSEcCtD
Mycophenolic acid—Abdominal pain—Prednisone—systemic scleroderma	8.28e-06	0.000131	CcSEcCtD
Mycophenolic acid—Body temperature increased—Prednisone—systemic scleroderma	8.28e-06	0.000131	CcSEcCtD
Mycophenolic acid—Hypotension—Methotrexate—systemic scleroderma	8.18e-06	0.000129	CcSEcCtD
Mycophenolic acid—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.97e-06	0.000126	CcSEcCtD
Mycophenolic acid—Insomnia—Methotrexate—systemic scleroderma	7.91e-06	0.000125	CcSEcCtD
Mycophenolic acid—Paraesthesia—Methotrexate—systemic scleroderma	7.86e-06	0.000124	CcSEcCtD
Mycophenolic acid—Dyspnoea—Methotrexate—systemic scleroderma	7.8e-06	0.000123	CcSEcCtD
Mycophenolic acid—Somnolence—Methotrexate—systemic scleroderma	7.78e-06	0.000123	CcSEcCtD
Mycophenolic acid—Dyspepsia—Methotrexate—systemic scleroderma	7.7e-06	0.000122	CcSEcCtD
Mycophenolic acid—Decreased appetite—Methotrexate—systemic scleroderma	7.61e-06	0.00012	CcSEcCtD
Mycophenolic acid—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.55e-06	0.00012	CcSEcCtD
Mycophenolic acid—Fatigue—Methotrexate—systemic scleroderma	7.54e-06	0.000119	CcSEcCtD
Mycophenolic acid—Asthenia—Prednisone—systemic scleroderma	7.51e-06	0.000119	CcSEcCtD
Mycophenolic acid—Pain—Methotrexate—systemic scleroderma	7.48e-06	0.000118	CcSEcCtD
Mycophenolic acid—Pruritus—Prednisone—systemic scleroderma	7.41e-06	0.000117	CcSEcCtD
Mycophenolic acid—Feeling abnormal—Methotrexate—systemic scleroderma	7.21e-06	0.000114	CcSEcCtD
Mycophenolic acid—Diarrhoea—Prednisone—systemic scleroderma	7.16e-06	0.000113	CcSEcCtD
Mycophenolic acid—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.15e-06	0.000113	CcSEcCtD
Mycophenolic acid—Dizziness—Prednisone—systemic scleroderma	6.92e-06	0.00011	CcSEcCtD
Mycophenolic acid—Body temperature increased—Methotrexate—systemic scleroderma	6.92e-06	0.000109	CcSEcCtD
Mycophenolic acid—Abdominal pain—Methotrexate—systemic scleroderma	6.92e-06	0.000109	CcSEcCtD
Mycophenolic acid—Vomiting—Prednisone—systemic scleroderma	6.66e-06	0.000105	CcSEcCtD
Mycophenolic acid—Rash—Prednisone—systemic scleroderma	6.6e-06	0.000104	CcSEcCtD
Mycophenolic acid—Dermatitis—Prednisone—systemic scleroderma	6.59e-06	0.000104	CcSEcCtD
Mycophenolic acid—Headache—Prednisone—systemic scleroderma	6.56e-06	0.000104	CcSEcCtD
Mycophenolic acid—Asthenia—Methotrexate—systemic scleroderma	6.28e-06	9.94e-05	CcSEcCtD
Mycophenolic acid—Nausea—Prednisone—systemic scleroderma	6.22e-06	9.84e-05	CcSEcCtD
Mycophenolic acid—Pruritus—Methotrexate—systemic scleroderma	6.19e-06	9.8e-05	CcSEcCtD
Mycophenolic acid—Diarrhoea—Methotrexate—systemic scleroderma	5.99e-06	9.48e-05	CcSEcCtD
Mycophenolic acid—Dizziness—Methotrexate—systemic scleroderma	5.79e-06	9.16e-05	CcSEcCtD
Mycophenolic acid—Vomiting—Methotrexate—systemic scleroderma	5.56e-06	8.81e-05	CcSEcCtD
Mycophenolic acid—Rash—Methotrexate—systemic scleroderma	5.52e-06	8.73e-05	CcSEcCtD
Mycophenolic acid—Dermatitis—Methotrexate—systemic scleroderma	5.51e-06	8.72e-05	CcSEcCtD
Mycophenolic acid—Headache—Methotrexate—systemic scleroderma	5.48e-06	8.68e-05	CcSEcCtD
Mycophenolic acid—Nausea—Methotrexate—systemic scleroderma	5.2e-06	8.23e-05	CcSEcCtD
